66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Get all the details here >>>

ALLO Insider Trading

Insider Ownership Percentage: 27.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $93,228.00

Allogene Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Allogene Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Allogene Therapeutics Share Price & Price History

Current Price: $4.54
Price Change: Price Increase of +0.18 (4.13%)
As of 02/23/2024 01:00 AM ET

This chart shows the closing price history over time for ALLO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Allogene Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/18/2023Deborah M MessemerDirectorSell18,640$2.70$50,328.0062,456View SEC Filing Icon  
8/7/2023Stephen MayoDirectorSell10,000$4.29$42,900.0025,328View SEC Filing Icon  
2/13/2023Veer BhavnagriGeneral CounselSell3,000$6.85$20,550.00577,677View SEC Filing Icon  
1/17/2023Veer BhavnagriGeneral CounselSell3,000$7.04$21,120.00580,677View SEC Filing Icon  
12/15/2022Veer BhavnagriGeneral CounselSell5,602$7.53$42,183.06583,677View SEC Filing Icon  
8/11/2022Owen N. WitteDirectorSell10,000$16.50$165,000.00223,271View SEC Filing Icon  
8/2/2022Rafael AmadoCMOSell2,000$11.97$23,940.00540,257View SEC Filing Icon  
7/5/2022Rafael AmadoCMOSell2,000$11.44$22,880.00542,257View SEC Filing Icon  
6/22/2022Owen N. WitteDirectorSell10,000$11.76$117,600.00233,271View SEC Filing Icon  
6/21/2022Rafael AmadoCMOSell2,000$11.18$22,360.00544,257View SEC Filing Icon  
5/19/2022Rafael AmadoCMOSell11,500$7.40$85,100.00546,257View SEC Filing Icon  
3/15/2022Alison MooreInsiderSell8,698$7.63$66,365.74View SEC Filing Icon  
3/15/2022David D ChangCEOSell23,648$7.65$180,907.20View SEC Filing Icon  
3/15/2022Eric Thomas SchmidtCFOSell11,469$7.63$87,508.47View SEC Filing Icon  
3/15/2022Rafael AmadoCMOSell5,169$7.71$39,852.99View SEC Filing Icon  
3/15/2022Veer BhavnagriGeneral CounselSell8,849$7.68$67,960.32View SEC Filing Icon  
1/12/2022Arie BelldegrunDirectorBuy155,039$12.60$1,953,491.40View SEC Filing Icon  
10/1/2021Rafael AmadoCMOSell11,507$24.35$280,195.45View SEC Filing Icon  
9/9/2021Owen N. WitteDirectorSell5,000$25.54$127,700.00221,182View SEC Filing Icon  
8/20/2021Owen N. WitteDirectorSell10,000$23.47$234,700.00View SEC Filing Icon  
8/16/2021Veer BhavnagriGeneral CounselSell5,000$21.00$105,000.00View SEC Filing Icon  
7/15/2021Veer BhavnagriGeneral CounselSell5,000$21.55$107,750.00426,353View SEC Filing Icon  
6/9/2021Owen N. WitteDirectorSell9,969$25.05$249,723.45236,182View SEC Filing Icon  
5/18/2021Veer BhavnagriGeneral CounselSell5,000$30.00$150,000.00426,353View SEC Filing Icon  
4/15/2021Veer BhavnagriGeneral CounselSell10,000$32.05$320,500.00431,353View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Allogene Therapeutics (NASDAQ:ALLO)

78.51% of Allogene Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ALLO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Allogene Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/16/2024Price T Rowe Associates Inc. MD2,371,472$7.61M0.0%-1.5%1.409%Search for SEC Filing on Google Icon
2/16/2024GSA Capital Partners LLP20,518$66K0.0%-83.8%0.012%Search for SEC Filing on Google Icon
2/15/2024Virtus ETF Advisers LLC34,163$0.11M0.1%+72.2%0.020%Search for SEC Filing on Google Icon
2/15/2024Barclays PLC184,907$0.59M0.0%-76.5%0.110%Search for SEC Filing on Google Icon
2/15/2024Vanguard Group Inc.9,030,825$28.99M0.0%-14.7%5.367%Search for SEC Filing on Google Icon
2/15/2024Voloridge Investment Management LLC145,841$0.47M0.0%-63.6%0.087%Search for SEC Filing on Google Icon
2/15/2024Voya Investment Management LLC38,347$0.12M0.0%+14.5%0.023%Search for SEC Filing on Google Icon
2/15/2024Nuveen Asset Management LLC357,558$1.15M0.0%-0.7%0.212%Search for SEC Filing on Google Icon
2/15/2024Price T Rowe Associates Inc. MD2,371,472$7.61M0.0%-1.5%1.409%Search for SEC Filing on Google Icon
2/15/2024Brevan Howard Capital Management LP98,120$0.32M0.0%+433.9%0.058%Search for SEC Filing on Google Icon
2/14/2024Royal Bank of Canada62,809$0.20M0.0%+11.3%0.037%Search for SEC Filing on Google Icon
2/14/2024Point72 Asset Management L.P.679,468$2.18M0.0%N/A0.404%Search for SEC Filing on Google Icon
2/14/2024Creative Planning28,310$91K0.0%-15.7%0.017%Search for SEC Filing on Google Icon
2/14/2024Cubist Systematic Strategies LLC82,544$0.27M0.0%-61.5%0.049%Search for SEC Filing on Google Icon
2/14/2024Caxton Associates LP775,093$2.49M0.1%+61.4%0.461%Search for SEC Filing on Google Icon
2/14/2024Pennant Investors LP128,400$0.41M0.1%N/A0.076%Search for SEC Filing on Google Icon
2/14/2024Nebula Research & Development LLC139,937$0.45M0.1%N/A0.083%Search for SEC Filing on Google Icon
2/14/2024Superstring Capital Management LP222,112$0.71M0.5%N/A0.132%Search for SEC Filing on Google Icon
2/14/2024Balyasny Asset Management L.P.15,730$50K0.0%N/A0.009%Search for SEC Filing on Google Icon
2/14/2024Cresset Asset Management LLC17,773$57K0.0%N/A0.011%Search for SEC Filing on Google Icon
2/13/2024Northern Trust Corp1,014,345$3.26M0.0%+17.9%0.603%Search for SEC Filing on Google Icon
2/13/2024American International Group Inc.46,967$0.15M0.0%+14.5%0.028%Search for SEC Filing on Google Icon
2/13/2024Public Employees Retirement Association of Colorado9,440$30K0.0%-92.9%0.006%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC 57,797$0.19M0.0%+600.7%0.034%Search for SEC Filing on Google Icon
2/13/2024Affinity Asset Advisors LLC400,000$1.28M0.2%N/A0.238%Search for SEC Filing on Google Icon
2/13/2024Goldman Sachs Group Inc.3,337,214$10.71M0.0%+137.0%1.983%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC229,008$0.74M0.0%-74.7%0.136%Search for SEC Filing on Google Icon
2/13/2024California State Teachers Retirement System112,458$0.36M0.0%+17.8%0.067%Search for SEC Filing on Google Icon
2/12/2024RPO LLC14,333$46K0.1%N/A0.009%Search for SEC Filing on Google Icon
2/12/2024Hsbc Holdings PLC44,664$0.14M0.0%+176.5%0.027%Search for SEC Filing on Google Icon
2/9/2024Primecap Management Co. CA5,281,886$16.96M0.0%0.0%3.139%Search for SEC Filing on Google Icon
2/9/2024UBS Group AG181,195$0.58M0.0%-12.4%0.108%Search for SEC Filing on Google Icon
2/9/2024Norges Bank270,770$0.87M0.0%N/A0.161%Search for SEC Filing on Google Icon
2/8/2024Mitsubishi UFJ Asset Management Co. Ltd.221,094$0.74M0.0%+20.2%0.131%Search for SEC Filing on Google Icon
2/7/2024Principal Financial Group Inc.34,613$0.11M0.0%-87.0%0.021%Search for SEC Filing on Google Icon
2/7/2024Dimensional Fund Advisors LP1,535,245$4.93M0.0%-16.5%0.912%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets123,518$0.40M0.0%-78.3%0.073%Search for SEC Filing on Google Icon
2/7/2024Calton & Associates Inc.21,060$68K0.0%N/A0.013%Search for SEC Filing on Google Icon
2/6/2024Charles Schwab Investment Management Inc.732,835$2.35M0.0%-6.2%0.435%Search for SEC Filing on Google Icon
2/6/2024Axxcess Wealth Management LLC10,677$34K0.0%N/A0.006%Search for SEC Filing on Google Icon
2/6/2024Los Angeles Capital Management LLC165,978$0.53M0.0%N/A0.099%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank214,800$0.69M0.0%+11.6%0.128%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.14,283$46K0.0%+23.1%0.008%Search for SEC Filing on Google Icon
1/31/2024Daiwa Securities Group Inc.32,498$0.10M0.0%+116.3%0.019%Search for SEC Filing on Google Icon
1/30/2024Zurcher Kantonalbank Zurich Cantonalbank 22,551$72K0.0%+55.4%0.013%Search for SEC Filing on Google Icon
1/30/2024Bourgeon Capital Management LLC50,700$0.16M0.0%-17.8%0.030%Search for SEC Filing on Google Icon
1/30/2024Cornercap Investment Counsel Inc.60,634$0.20M0.0%N/A0.036%Search for SEC Filing on Google Icon
1/30/2024Vontobel Holding Ltd.18,000$58K0.0%+28.6%0.011%Search for SEC Filing on Google Icon
1/26/2024Cerity Partners LLC517,581$1.66M0.0%N/A0.308%Search for SEC Filing on Google Icon
1/26/2024Aaron Wealth Advisors LLC10,729$34K0.0%N/A0.006%Search for SEC Filing on Google Icon
1/24/2024Mirae Asset Global Investments Co. Ltd.195,480$0.63M0.0%-54.4%0.116%Search for SEC Filing on Google Icon
1/24/2024Arizona State Retirement System30,458$98K0.0%+22.2%0.018%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.19,467$62K0.0%+353.0%0.012%Search for SEC Filing on Google Icon
1/18/2024McGlone Suttner Wealth Management Inc.8,376$27K0.0%N/A0.005%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC53,484$0.17M0.0%N/A0.032%Search for SEC Filing on Google Icon
1/10/2024Nordea Investment Management AB740,683$2.38M0.0%-3.1%0.440%Search for SEC Filing on Google Icon
1/8/2024Harbor Capital Advisors Inc.73,510$0.24M0.0%+7.3%0.044%Search for SEC Filing on Google Icon
1/5/2024Exchange Traded Concepts LLC36,040$0.12M0.0%+34.0%0.021%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.10,587,804$33.56M0.0%+41.1%6.292%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.338,756$1.07M0.0%+20.4%0.201%Search for SEC Filing on Google Icon
11/30/2023American Century Companies Inc.55,536$0.18M0.0%+28.7%0.033%Search for SEC Filing on Google Icon
11/24/2023Deutsche Bank AG43,290$0.14M0.0%-81.7%0.026%Search for SEC Filing on Google Icon
11/24/2023EP Wealth Advisors LLC10,850$34K0.0%N/A0.006%Search for SEC Filing on Google Icon
11/16/2023Creative Planning33,601$0.11M0.0%N/A0.020%Search for SEC Filing on Google Icon
11/16/2023GTS Securities LLC10,994$35K0.0%N/A0.007%Search for SEC Filing on Google Icon
11/16/2023Tudor Investment Corp Et Al73,998$0.24M0.0%+581.2%0.044%Search for SEC Filing on Google Icon
11/16/2023Penserra Capital Management LLC28,284$89K0.0%+33.6%0.017%Search for SEC Filing on Google Icon
11/15/2023GSA Capital Partners LLP126,812$0.40M0.0%N/A0.075%Search for SEC Filing on Google Icon
11/15/2023JPMorgan Chase & Co.6,910,882$21.91M0.0%+12.7%4.107%Search for SEC Filing on Google Icon
11/15/2023Legal & General Group Plc81,309$0.26M0.0%+5.3%0.048%Search for SEC Filing on Google Icon
11/15/2023Alps Advisors Inc.123,718$0.39M0.0%+15.4%0.074%Search for SEC Filing on Google Icon
11/15/2023Ameriprise Financial Inc.134,591$0.43M0.0%+21.1%0.080%Search for SEC Filing on Google Icon
11/14/2023Corton Capital Inc.12,628$40K0.0%-52.5%0.008%Search for SEC Filing on Google Icon
11/14/2023Caxton Associates LP480,104$1.52M0.2%+590.0%0.285%Search for SEC Filing on Google Icon
11/14/2023MBB Public Markets I LLC57,306$0.18M0.0%-33.2%0.034%Search for SEC Filing on Google Icon
11/14/2023California State Teachers Retirement System95,464$0.30M0.0%-7.9%0.057%Search for SEC Filing on Google Icon
11/14/2023Tower Research Capital LLC TRC 8,249$26K0.0%-39.5%0.005%Search for SEC Filing on Google Icon
11/14/2023Primecap Management Co. CA5,284,386$16.75M0.0%-6.3%3.140%Search for SEC Filing on Google Icon
11/14/2023Profund Advisors LLC130,639$0.41M0.0%-4.8%0.078%Search for SEC Filing on Google Icon
11/13/2023LPL Financial LLC38,007$0.12M0.0%+82.3%0.023%Search for SEC Filing on Google Icon
11/13/2023Hsbc Holdings PLC16,155$51K0.0%N/A0.010%Search for SEC Filing on Google Icon
11/13/2023FMR LLC25,143,931$79.71M0.0%+0.9%14.942%Search for SEC Filing on Google Icon
11/13/2023Nordea Investment Management AB764,488$2.42M0.0%-1.4%0.454%Search for SEC Filing on Google Icon
11/13/2023Rafferty Asset Management LLC904,403$2.87M0.0%+2.2%0.537%Search for SEC Filing on Google Icon
11/9/2023Rhumbline Advisers139,145$0.44M0.0%-3.5%0.083%Search for SEC Filing on Google Icon
11/9/2023Deutsche Bank AG43,290$0.14M0.0%-81.7%0.026%Search for SEC Filing on Google Icon
11/9/2023Citigroup Inc.338,756$1.07M0.0%+20.4%0.201%Search for SEC Filing on Google Icon
11/9/2023UBS Group AG206,759$0.66M0.0%-30.4%0.123%Search for SEC Filing on Google Icon
11/8/2023Charles Schwab Investment Management Inc.781,328$2.48M0.0%+17.4%0.466%Search for SEC Filing on Google Icon
11/8/2023Dorsey & Whitney Trust CO LLC12,265$39K0.0%N/A0.007%Search for SEC Filing on Google Icon
11/8/2023Swiss National Bank192,400$0.61M0.0%+3.0%0.115%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC786,793$2.50M0.0%+17.6%0.469%Search for SEC Filing on Google Icon
11/6/2023Victory Capital Management Inc.11,603$37K0.0%N/A0.007%Search for SEC Filing on Google Icon
11/6/2023Ieq Capital LLC66,178$0.21M0.0%+45.4%0.039%Search for SEC Filing on Google Icon
11/2/2023Principal Financial Group Inc.266,154$0.84M0.0%+1.7%0.159%Search for SEC Filing on Google Icon
11/1/2023Bourgeon Capital Management LLC61,700$0.20M0.0%-7.8%0.037%Search for SEC Filing on Google Icon
10/27/2023TD Asset Management Inc237,836$0.75M0.0%+19.2%0.142%Search for SEC Filing on Google Icon
10/26/2023Mirae Asset Global Investments Co. Ltd.428,493$1.36M0.0%+8.3%0.256%Search for SEC Filing on Google Icon
10/20/2023Harbor Capital Advisors Inc.68,519$0.22M0.0%+18.0%0.041%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC669,197$3.33M0.0%+33.7%0.399%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Allogene Therapeutics logo
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell ALL. The company also develops ALLO-501, an anti-CD19 allogeneic CAR T cell product candidate that is in Phase I clinical trial for the treatment of R/R non-Hodgkin lymphoma; and ALLO-501A, which is in Phase I/II clinical trial for the treatment R/R large B-cell lymphoma or transformed follicular lymphoma. In addition, it is developing ALLO-715, an allogeneic CAR T cell product candidate that is in a Phase I clinical trial for treating R/R multiple myeloma; ALLO-605, an allogeneic CAR T cell product candidate for the treatment of multiple myeloma; ALLO-647, an anti-CD52 monoclonal antibody; CD70 to treat renal cell cancer; ALLO- 316, an allogeneic CAR T cell product candidates for the treatment of immune checkpoint inhibitor; DLL3 for the treatment of small cell lung cancer and other aggressive neuroendocrine tumors; and Claudin 18.2 for the treatment of gastric and pancreatic cancer. The company has license and collaboration agreements with Pfizer Inc.; Servier; Cellectis S.A.; and Notch Therapeutics Inc. It also has a strategic collaboration agreement with The University of Texas MD Anderson Cancer Center for the preclinical and clinical investigation of allogeneic CAR T cell product candidates; and a strategic partnership with Foresight Diagnostics to develop MRD-based In-Vitro Diagnostic for use in ALPHA3. The company was incorporated in 2017 and is headquartered in South San Francisco, California.
Read More on Allogene Therapeutics

Today's Range

Now: $4.54
Low: $4.32
High: $4.59

50 Day Range

MA: $3.62
Low: $2.76
High: $4.96

52 Week Range

Now: $4.54
Low: $2.23
High: $7.14

Volume

1,347,446 shs

Average Volume

2,340,425 shs

Market Capitalization

$763.99 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.73

Who are the company insiders with the largest holdings of Allogene Therapeutics?

Allogene Therapeutics' top insider shareholders include:
  1. Veer Bhavnagri (General Counsel)
  2. Rafael Amado (CMO)
  3. Owen N Witte (Director)
  4. Deborah M Messemer (Director)
  5. Stephen Mayo (Director)
  6. Alison Moore (Insider)
  7. David D Chang (CEO)
  8. Eric Thomas Schmidt (CFO)
Learn More about top insider investors at Allogene Therapeutics.

Who are the major institutional investors of Allogene Therapeutics?

Allogene Therapeutics' top institutional shareholders include:
  1. Vanguard Group Inc. — 5.37%
  2. Primecap Management Co. CA — 3.14%
  3. Goldman Sachs Group Inc. — 1.98%
  4. Price T Rowe Associates Inc. MD — 1.41%
  5. Price T Rowe Associates Inc. MD — 1.41%
  6. Dimensional Fund Advisors LP — 0.91%
Learn More about top institutional investors of Allogene Therapeutics stock.

Which institutional investors are selling Allogene Therapeutics stock?

During the previous quarter, ALLO stock was sold by these institutional investors:
  1. Vanguard Group Inc.
  2. Rafferty Asset Management LLC
  3. Barclays PLC
  4. BNP Paribas Financial Markets
  5. Dimensional Fund Advisors LP
  6. Voloridge Investment Management LLC
  7. Mirae Asset Global Investments Co. Ltd.
  8. Principal Financial Group Inc.
Within the previous year, company insiders that have sold Allogene Therapeutics company stock include:
  1. Veer Bhavnagri (General Counsel)
  2. Rafael Amado (CMO)
Learn More investors selling Allogene Therapeutics stock.

Which institutional investors are buying Allogene Therapeutics stock?

During the previous quarter, ALLO stock was acquired by institutional investors including:
  1. Goldman Sachs Group Inc.
  2. Point72 Asset Management L.P.
  3. Cerity Partners LLC
  4. Affinity Asset Advisors LLC
  5. Caxton Associates LP
  6. Norges Bank
  7. Superstring Capital Management LP
  8. Los Angeles Capital Management LLC